Elevance Health has been in a holding pattern since December 2024, trading around 383.92. Analysts highlight that the company is using debt reasonably well, as indicated by four key measures. The stock's performance post-Q1 earnings is under scrutiny, with investors evaluating whether to buy, sell, or hold.